Indaptus Therapeutics is trading at $3.40, up 10.19%, with the rally’s precise reason unclear.
- It rebounded from the September 21, 2026 close of $3.09 after a volatile series of sessions.
- No new company-specific announcement or major catalyst was identified for September 22, 2026; available coverage lists the earlier-September $24 million private placement but does not directly link today’s move to it.
- The broader market was modestly mixed: Nasdaq rose 0.48% and S&P 500 0.12%, offering limited explanatory support.